Danaher | DHR - Les Charges D'Exploitation





Les Charges D'Exploitation Changement Date
Abbott USD 11.66B 1.2B 2026-09
Agilent USD 1.43B 2M 2026-06
Align Technology USD 821.72M 43.15M 2026-09
Becton, Dickinson and Co. USD 4.16B 20.25B 2026-09
Bio Techne USD 226.2M 9.72M 2026-06
Bio-Rad Laboratories USD 7.6B 429.1M 2026-09
Boston Scientific USD 4.13B 72M 2026-09
Bruker USD 790.5M 21.6M 2026-09
Charles River Laboratories USD 3.23B 387.38M 2026-09
Danaher USD 53.62B 1.04B 2026-09
Dentsply International USD 1.36B 4M 2026-09
Edwards Lifesciences USD 10.86B 9.64B 2026-09
ESCO Technologies USD 1.62B 31.84M 2026-06
Fortive USD 871.6M 15.3M 2026-09
Henry Schein USD 3.27B 8M 2026-09
Illumina USD 525M 374M 2026-09
Intuitive Surgical USD 2B 86.5M 2026-09
IQVIA Holdings USD 3.82B 2.05B 2026-09
Keysight Technologies USD 1.35B 78M 2026-06
Laboratory Of America USD 3.39B 117.6M 2026-09
Medtronic USD 7.92B 203M 2026-06
Mettler Toledo International USD 77.66M 662.11M 2026-09
Myriad Genetics USD 212.8M 16.2M 2025-12
OraSure Technologies USD 40.35M 2.45M 2025-12
Quest Diagnostics USD 2.62B 34M 2026-09
Quidel USD 606.8M 39.4M 2026-09
Repligen USD 185.01M 2.01M 2026-09
Revvity USD 604.27M 719K 2026-09
Roper Industries USD 1.54B 18.4M 2026-09
Stryker USD 4.8B 118M 2026-06
Thermo Fisher Scientific USD 9.68B 134M 2026-09
Waters USD 527M 592M 2026-06
Zimmer Biomet Holdings USD 1.72B 110.9M 2026-09